Analysis of possible WT1 RNA processing in primary Wilms tumors.
WT1 RNA processing abnormalities have been suggested to play a role in the development of Wilms tumor by reports of editing at codon 280 in the rat WT1 transcript (codon 281 in humans) and aberrant splicing of exon 2 in WT1 transcripts from Wilms tumor xenograft cell lines. Both events result in a functionally changed WT1 protein and are potential mechanisms of altering normal protein function in the absence of WT1 DNA mutations. To determine whether either of these RNA processing events occurs in primary Wilms tumors, we analysed WT1 mRNA from 15 primary tumors. There was no evidence of WT1 RNA editing at codon 281, and only one primary tumor displayed aberrant splicing of exon 2. Sequence and Southern analysis of DNA from this tumor did not reveal any alteration in or around exon 2. These results suggest that neither RNA editing at codon 281 nor aberrant exon 2 splicing is a frequent mechanism of WT1 alteration during tumorigenesis.
Gunning
K B
KB
Department of Experimental Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, USA.
Cohn
S L
SL
Tomlinson
G E
GE
Strong
L C
LC
Huff
V
V
D017398:Alternative Splicing; D001483:Base Sequence; D003062:Codon; D004268:DNA-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics* / Q000502:physiology; D005091:Exons; D016147:Genes, Tumor Suppressor; D006801:Humans; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012334:RNA, Neoplasm / Q000235:genetics* / Q000378:metabolism*; D014157:Transcription Factors / Q000096:biosynthesis* / Q000235:genetics* / Q000502:physiology; D025721:WT1 Proteins; D009396:Wilms Tumor / Q000235:genetics* / Q000378:metabolism*
D003062:Codon; D004268:DNA-Binding Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D014157:Transcription Factors; D025721:WT1 Proteins